Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-03-24Clinical Trial Update: T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer [Phase 2]
Phase 2 trial update on T cell receptor immunotherapy targeting NY-ESO-1 in NY-ESO-1 expressing cancers; study is completed with results pos…
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011) [Phase 1]
Phase 1 study evaluating pembrolizumab monotherapy and combination therapy in advanced solid tumors and lung cancer; completed with results …
-
CLINICAL_TRIALS trial_result · 2021-03-22Clinical Trial Update: Adjuvant CCRT vs CT in Minimal N2 NSCLC [Phase 2]
Phase 2 trial comparing adjuvant concurrent chemoradiotherapy to chemotherapy in minimal N2 non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Gilotrif (Afatinib) in Advanced Non-Small Cell Lung Cancer Patients Pre-treated With Erlotinib or Gefitinib [Phase 2]
Phase 2 trial evaluating afatinib (Gilotrif) in advanced non-small cell lung cancer patients who were pre-treated with erlotinib or gefitini…
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: S1403, Afatinib Dimaleate With or Without Cetuximab in Treating Patients With Newly Diagnosed Stage IV or Recurrent, EGFR Mutation Positive Non-small Cell Lung Cancer [Phase 2, Phase 3]
A phase 2/3 trial (S1403) evaluated afatinib with or without cetuximab for newly diagnosed stage IV or recurrent EGFR-mutant non-small cell …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-03-17Clinical Trial Update: Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC [Phase 3]
Phase 3 clinical trial update for paclitaxel micelles/injection with cisplatin as first-line therapy in advanced non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: A Study of SHR-1210 in Combination With Carboplatin + Paclitaxel in Subjects With Squamous NSCLC [Phase 3]
Phase 3 study of SHR-1210 with carboplatin and paclitaxel in squamous non-small cell lung cancer is ongoing, with status not provided.
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Concomitant Mutation NSCLC [Phase 3]
A Phase 3 trial evaluating anlotinib combined with icotinib as first-line therapy for patients with EGFR-mutant non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-03-15Clinical Trial Update: Study of Anlotinib Combined With Icotinib as the First-line Treatment in Patients With EGFR Mutation-positive NSCLC [Phase 2]
Phase 2 trial assessing first-line therapy with Anlotinib plus Icotinib in EGFR mutation-positive non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-10Clinical Trial Update: Lorlatinib Combinations in Lung Cancer [Phase 1, Phase 2]
Phase 1/2 trial exploring lorlatinib combinations in lung cancer with ALK translocations and related resistant/metabolic alterations; status…
-
CLINICAL_TRIALS trial_result · 2021-03-09Clinical Trial Update: A Study of Lorlatinib in Advanced ALK and ROS1 Rearranged Lung Cancer With CNS Metastasis in the Absence of Measurable Extracranial Lesions [Phase 2]
Phase 2 trial update for lorlatinib in advanced ALK/ROS1-rearranged NSCLC with CNS metastasis and no measurable extracranial lesions.
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: Almonertinib for Advanced NSCLC Patients With Rare Mutations in EGFR [Phase 2]
Phase 2 clinical trial update on almonertinib for advanced non-small cell lung cancer with rare EGFR mutations.
-
CLINICAL_TRIALS trial_result · 2021-03-08Clinical Trial Update: Almonertinib Combined With Pyrotinib in the Treatment of Advanced NSCLC Patients With HER-2 Amplification/Mutation After EGFR-TKI Resistance [Phase 2]
A Phase 2 trial evaluating almonertinib combined with pyrotinib for advanced non-small cell lung cancer with HER-2 amplification/mutation af…
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update on CyberKnife radiosurgical treatment for inoperable early-stage non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-03-05Clinical Trial Update: Sensitivity of PDL-1-analysis From Pleural Effusion in Non-small Cell Lung Cancer
A completed clinical trial evaluating PD-L1 analysis sensitivity from pleural effusion in non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: Study Comparing Veliparib Plus Carboplatin and Paclitaxel Versus Investigator's Choice of Standard Chemotherapy in Adults Receiving First Cytotoxic Chemotherapy for Metastatic or Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) and Who Are Current or Former Smokers [Phase 3]
Phase 3 trial comparing veliparib plus carboplatin and paclitaxel versus investigator's choice chemotherapy in first-line metastatic/advance…
-
CLINICAL_TRIALS trial_result · 2021-02-26Clinical Trial Update: Adjuvant Toripalimab Plus Chemotherapy for EGFR/ALK Mutation Negative Stage II-IIIB(N2) NSCLC (LungMate-008) [Phase 3]
Phase 3 trial evaluating adjuvant toripalimab plus chemotherapy for EGFR/ALK mutation-negative stage II-IIIB(N2) non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: Camrelizumab Combined With SRT/WBRT and Chemotherapy in Patients With Brain Metastases of Driven Gene-negative NSCLC [Phase 3]
Phase 3 trial evaluating camrelizumab with SRT/WBRT and chemotherapy in brain metastases from driver gene-negative non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2021-02-24Clinical Trial Update: GIOTRIF rPMS in Korean Patients With NSCLC
A completed clinical trial update for GIOTRIF rPMS in Korean patients with non-small cell lung carcinoma (NSCLC) has results posted.
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Bevacizumab or Pemetrexed Disodium Alone or In Combination After Induction Therapy in Treating Patients With Advanced Non-Squamous Non-Small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing bevacizumab or pemetrexed disodium alone or in combination after induction therapy in advanced non-squamous non-sm…
-
CLINICAL_TRIALS trial_result · 2021-02-23Clinical Trial Update: Clinical Trial of Kanglaite Injection (KLTi) in Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 4]
Phase 4 clinical trial update for Kanglaite Injection (KLTi) in advanced non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Nintedanib in Molecularly Selected Patients With Advanced Non-Small Cell Lung Cancer [Phase 2]
This update presents results from a Phase 2 study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer. T…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Neoadjuvant Durvalumab/Anlotinib /Chemotherapy Plus Curative Resection in Stage III Non-Small-Cell Lung Cancer : A Single-arm Phase II Study [Phase 2]
A single-arm Phase II trial evaluating neoadjuvant durvalumab, anlotinib, and chemotherapy followed by curative resection in stage III non-s…
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Study of Patupilone in Patients With Brain Metastasis From Non-small Cell Lung Cancer [Phase 2]
Phase 2 trial update for patupilone in patients with brain metastasis from non-small cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2021-02-21Clinical Trial Update: Open Label Extension Study of Conatumumab and Ganitumab (AMG 479) [Phase 2]
Open-label extension study of Conatumumab and Ganitumab (AMG 479) in a Phase 2 trial for advanced solid tumors; completed with results poste…